A retrospective analysis of the relationship between the oral administration of probiotics during pregnancy and the Edinburgh postnatal depression scale at 1 month after delivery
Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychol...
Saved in:
Published in | Journal of Japan Society of Perinatal and Neonatal Medicine Vol. 56; no. 2; pp. 218 - 223 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | Japanese |
Published |
Japan Society of Perinatal and Neonatal Medicine
2020
一般社団法人 日本周産期・新生児医学会 |
Subjects | |
Online Access | Get full text |
ISSN | 1348-964X 2435-4996 |
DOI | 10.34456/jjspnm.56.2_218 |
Cover
Abstract | Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression. |
---|---|
AbstractList | Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression.
【目的】妊娠時におけるプロバイオティクス(PRO)経口投与と産後1カ月のエジンバラ産後うつ病自己評価(EPDS)との関連を後方視的に検討した.【方法】2017年3月から2018年12月に精神疾患合併妊婦,特定妊婦を除く916名を対象に産後1カ月時EPDSを実施した.EPDS陽性は,合計点≧9点あるいは質問事項10番≧1点の場合と定義した.妊娠中CBM588を消化器症状に対し2週間以上投与し,かつ投与開始後消化器症状が改善した78例をPRO投与ありと定義した.PRO投与とEPDS陽性,高齢妊娠,母体肥満,妊娠糖尿病,37週未満の早産の関連につき多変量ロジスティック解析を用いて検討した.有意水準はP<0.05とした.【結果】PRO投与はEPDS陽性,高齢妊娠,早産との関連を認めた.【考察】PRO投与は,産後の抑うつ状態の改善に関与する可能性が示唆された. Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression. |
Author | Yoshizato, Toshiyuki Okura, Naofumi Kawakami, Kosuke |
Author_FL | 大蔵 尚文 吉里 俊幸 川上 浩介 |
Author_FL_xml | – sequence: 1 fullname: 川上 浩介 – sequence: 2 fullname: 吉里 俊幸 – sequence: 3 fullname: 大蔵 尚文 |
Author_xml | – sequence: 1 fullname: Okura, Naofumi organization: Department of Obstetrics and Gynecology, National Hospital Organization Kokura Medical Center – sequence: 1 fullname: Yoshizato, Toshiyuki organization: Department of Obstetrics and Gynecology, School of Medicine, Kurume University – sequence: 1 fullname: Kawakami, Kosuke organization: Department of Obstetrics and Gynecology, National Hospital Organization Kokura Medical Center |
BackLink | https://cir.nii.ac.jp/crid/1390004222615375104$$DView record in CiNii |
BookMark | eNo9kU9P3DAQxa2KSt0C9x596DVb_9_kVoQoRULiwoFbNLEnG6-ydmQb0H4tPiFmF3GZkeb95ulp5ic5CzEgIb84W0ultPmz2-Ul7NfarEUvePuNrISSulFdZ87IikvVNp1RTz_IZc5-YEpttNKcr8jbFU1YUswL2uJfkEKA-ZB9pnGkZcKqzlB8DHnyCx2wvCKGoxATzBTc3gefSzoyHztLioOPxdtM3XPyYVsnuA0Q7KF6u-PqjfNheE7biS4xlwClOjmsXA1XXbKFuQYplNN9DGWiMBZMlZhrwHS4IN9HmDNefvZz8vjv5vH6f3P_cHt3fXXf7FqjGjdIC8KMzhnFWKtG6aQAIezQCcbMRo-Saw2q04jGyM5wC1iRbqiggVaek98n2-B9b_1H5bJjjCkhhOFabjRnqmJ_T9guF9hivyS_h3ToIdUbzNifPtNr04tj4e2XZCdIPQb5DtfHkC0 |
ContentType | Journal Article |
Copyright | 2020 Journal of Japan Society of Perinatal and Neonatal Medicine |
Copyright_xml | – notice: 2020 Journal of Japan Society of Perinatal and Neonatal Medicine |
DBID | RYH |
DOI | 10.34456/jjspnm.56.2_218 |
DatabaseName | CiNii Complete |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | 妊娠中プロバイオティクス経口投与と産後1カ月におけるエジンバラ産後うつ病自己評価との関連についての後方視的検討 |
DocumentTitle_FL | 妊娠中プロバイオティクス経口投与と産後1カ月におけるエジンバラ産後うつ病自己評価との関連についての後方視的検討 |
EISSN | 2435-4996 |
EndPage | 223 |
ExternalDocumentID | 130007899052 article_jjspnm_56_2_56_218_article_char_en |
GroupedDBID | .55 3O- ABJNI ALMA_UNASSIGNED_HOLDINGS JMI JSF JSH MOJWN OK1 RJT RZJ X7L X7M RYH |
ID | FETCH-LOGICAL-j864-db3ca26fdd640084f3d32a22cb9200675f3155a495ee663961caed329b3d36a83 |
ISSN | 1348-964X |
IngestDate | Thu Jun 26 22:15:23 EDT 2025 Wed Sep 03 06:24:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j864-db3ca26fdd640084f3d32a22cb9200675f3155a495ee663961caed329b3d36a83 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jjspnm/56/2/56_218/_article/-char/en |
PageCount | 6 |
ParticipantIDs | nii_cinii_1390004222615375104 jstage_primary_article_jjspnm_56_2_56_218_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2020 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – year: 2020 text: 2020 |
PublicationDecade | 2020 |
PublicationTitle | Journal of Japan Society of Perinatal and Neonatal Medicine |
PublicationTitleAlternate | jjspnm |
PublicationTitle_FL | 日本周産期・新生児医学会雑誌 jjspnm |
PublicationYear | 2020 |
Publisher | Japan Society of Perinatal and Neonatal Medicine 一般社団法人 日本周産期・新生児医学会 |
Publisher_xml | – name: Japan Society of Perinatal and Neonatal Medicine – name: 一般社団法人 日本周産期・新生児医学会 |
References | 1) 竹田省:妊産婦の自殺防止.周産期医学 2017;5:623-7 15) Miyaoka T, Kanayama M, Wake R, et al.:Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder:A prospective open-label trial. Clin Neuropharmacol 2018;41:151-5 3) Tam WH1, Chung T:Psychosomatic disorders in pregnancy. Curr Opin Obstet Gynecol 2007;19:126-32 8) Logan AC, Katzman M:Major depressive disorder:probiotics may be an adjuvant therapy. Med Hypotheses 2005;64:533-8 17) Liu RT, Walsh RFL, Sheehan AE:Prebiotics and probiotics for depression and anxiety:A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 2019;102:13-23 2) Melville JL, Gavin A, Guo Y, et al.:Depressive disorders during pregnancy:prevalence and risk factors in a large urban sample. Obstet Gynecol 2010;116:1064-70 21) 古賀泰裕:プロバイオティクス・プレバイオティクスの歴史,概念,適応.臨床と研究 2018;95:937-41 5) 岡野禎治,村田真理子,増地聡子,他:日本版エジンバラ産後うつ病自己評価表(EPDS)の信頼性と妥当性.神科診断学 1996;7:525-33 12) 光岡知足:プロバイオティクスの歴史と進化.日本乳酸菌学会誌 2011;22:26-37 19) Myhre R, Brantsæter AL, Myking S, et al.:Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr 2011;93:151-7 6) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5):American Psychiatric Association, 2000. 14) Schroeder FA, Lin CL, Crusio WE, et al.:Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007;62:55-64 16) Slykerman RF, Hood F, Wickens K, et al.:Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine 2017;24:159-65 4) Lyell DJ, Chambers AS, Steidtmann D, et al.:Antenatal identification of major depressive disorder:a cohort study. Am J Obstet Gynecol 2012;207:506 7) Freedman R, Lewis DA, Michels R, et al.:The initial field trials of DSM-5:new blooms and old thorns. Am J Psychiatry 2013;170:1-5 10) 海老根真由美,斉藤正博,高井泰,他:産後うつ病のスクリーニング-総合周産期母子医療センターでの実施成績.産婦人科の実際 2007;56:943-50 18) 山城雄一郎,和田万里子,永田智:小児の抗癌剤治療に伴う重症粘膜炎のプロバイオティクス治療.医学のあゆみ 2012;243:156-60 20) Jarde A, Lewis-Mikhael AM, Moayyedi P, et al.:Pregnancy outcomes in women taking probiotics or prebiotics:a systematic review and meta-analysis. BMC Pregnancy Childbirth 2018;18:14 11) 宗田聡:EPDS活用ガイド.東京:南山堂,2017 13) Tsankova N, Renthal W, Kumar A, et al.:Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-67 9) IADPSG Consensus Panel:International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82 |
References_xml | – reference: 14) Schroeder FA, Lin CL, Crusio WE, et al.:Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007;62:55-64 – reference: 15) Miyaoka T, Kanayama M, Wake R, et al.:Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder:A prospective open-label trial. Clin Neuropharmacol 2018;41:151-5 – reference: 17) Liu RT, Walsh RFL, Sheehan AE:Prebiotics and probiotics for depression and anxiety:A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 2019;102:13-23 – reference: 7) Freedman R, Lewis DA, Michels R, et al.:The initial field trials of DSM-5:new blooms and old thorns. Am J Psychiatry 2013;170:1-5 – reference: 8) Logan AC, Katzman M:Major depressive disorder:probiotics may be an adjuvant therapy. Med Hypotheses 2005;64:533-8 – reference: 9) IADPSG Consensus Panel:International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82 – reference: 19) Myhre R, Brantsæter AL, Myking S, et al.:Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr 2011;93:151-7 – reference: 16) Slykerman RF, Hood F, Wickens K, et al.:Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine 2017;24:159-65 – reference: 11) 宗田聡:EPDS活用ガイド.東京:南山堂,2017 – reference: 1) 竹田省:妊産婦の自殺防止.周産期医学 2017;5:623-7 – reference: 10) 海老根真由美,斉藤正博,高井泰,他:産後うつ病のスクリーニング-総合周産期母子医療センターでの実施成績.産婦人科の実際 2007;56:943-50 – reference: 2) Melville JL, Gavin A, Guo Y, et al.:Depressive disorders during pregnancy:prevalence and risk factors in a large urban sample. Obstet Gynecol 2010;116:1064-70 – reference: 4) Lyell DJ, Chambers AS, Steidtmann D, et al.:Antenatal identification of major depressive disorder:a cohort study. Am J Obstet Gynecol 2012;207:506 – reference: 5) 岡野禎治,村田真理子,増地聡子,他:日本版エジンバラ産後うつ病自己評価表(EPDS)の信頼性と妥当性.神科診断学 1996;7:525-33 – reference: 18) 山城雄一郎,和田万里子,永田智:小児の抗癌剤治療に伴う重症粘膜炎のプロバイオティクス治療.医学のあゆみ 2012;243:156-60 – reference: 6) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5):American Psychiatric Association, 2000. – reference: 12) 光岡知足:プロバイオティクスの歴史と進化.日本乳酸菌学会誌 2011;22:26-37 – reference: 13) Tsankova N, Renthal W, Kumar A, et al.:Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-67 – reference: 20) Jarde A, Lewis-Mikhael AM, Moayyedi P, et al.:Pregnancy outcomes in women taking probiotics or prebiotics:a systematic review and meta-analysis. BMC Pregnancy Childbirth 2018;18:14 – reference: 3) Tam WH1, Chung T:Psychosomatic disorders in pregnancy. Curr Opin Obstet Gynecol 2007;19:126-32 – reference: 21) 古賀泰裕:プロバイオティクス・プレバイオティクスの歴史,概念,適応.臨床と研究 2018;95:937-41 |
SSID | ssib044754511 ssib039893120 ssib058493940 ssj0002672305 ssib041163657 ssib005796665 ssib043658147 |
Score | 2.183173 |
Snippet | Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at... |
SourceID | nii jstage |
SourceType | Publisher |
StartPage | 218 |
SubjectTerms | Edinburgh postnatal depression scale Maternal postnatal depression Probiotics |
Title | A retrospective analysis of the relationship between the oral administration of probiotics during pregnancy and the Edinburgh postnatal depression scale at 1 month after delivery |
URI | https://www.jstage.jst.go.jp/article/jjspnm/56/2/56_218/_article/-char/en https://cir.nii.ac.jp/crid/1390004222615375104 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Japan Society of Perinatal and Neonatal Medicine, 2020, Vol.56(2), pp.218-223 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXKcuGCQIBYYJEP3KKUxHGc-FihotWuuqci7S1yGge1pUmVJkK7B34U_w-JGTvNR4UE7MVK7CRtMn4zz_bMmJAPaZZnXhTlbgYDapfzHDAXq8iFSk_nPGZKYTTy4kZcfuFXt-HtZPJr4LXU1Ol0df_HuJKHSBXqQK4YJfsfku0eChVwDPKFEiQM5T_JeOZUuq7KY7SkowYZRozr4NHTbeiRhQ0mLF-N8uYa12eTlMkkbm7DF_eV_oopOe46T8s5GDuzNOPsy0NdmM1HOnfawjmAzDVGSPoOfAaMm2s3If-GDiCjNeQBF74Ck110HqTolodRiebZ-Ls3urQnixNPgGv1XW3Vbu1cl4dmq3sVBm98b3a1waO7ZrvuJpO3TaXAppR5s1sPpzyY1xuih_wbq9gDDopdWG_QqTZ1DKiiCyM-MbQGNs152-vZSLXHA5bAbJT0qQEKOBBStECbw77YTUMxZUl34yitNy4jYqp_6YXAIB6zKPLRI3XxY96rxwjGov0idCCBW_o9u-c-cOnBojWHk9jvR4eYynGYfQ6opgyO2RKRqDARwQA0NFMS7dexC_nmLT6evANQtA0MWDATxaNivR6wsOUz8rTtMnRmsfCcTDbqBfk5oyMc0CMOaJlT6LN0iAPa4sA0IA7oGAd4T48DanFAOxzAszNza4cD2uGA9jigBgdU1dSnBgfU4IAecfCSLD_Pl58u3XYvEncTC-5mabBSTORZJjhuQZEHWcAUY6tU4pxcFOYBEHPFZag1cHgp_JXScIlM4UKh4uAVOSvKQr8mVILujoGkR34GBjT2ZAx0KQuFzFcyDEPvnEj7nZO9zTeTtPolsQJJQpEwU_hx14QhmqARz8kFiCaBrg8ljO08k-KP4aAuAuPL3_yl_S15gnizU4zvyFldNfoCSHedvjdd8zcpeN0F |
linkProvider | ISSN International Centre |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+retrospective+analysis+of+the+relationship+between+the+oral+administration+of+probiotics+during+pregnancy+and+the+Edinburgh+postnatal+depression+scale+at+1+month+after+delivery&rft.jtitle=Journal+of+Japan+Society+of+Perinatal+and+Neonatal+Medicine&rft.au=Kawakami+Kosuke&rft.au=Yoshizato+Toshiyuki&rft.au=Okura+Naofumi&rft.date=2020&rft.pub=Japan+Society+of+Perinatal+and+Neonatal+Medicine&rft.issn=1348-964X&rft.eissn=2435-4996&rft.volume=56&rft.issue=2&rft.spage=218&rft.epage=223&rft_id=info:doi/10.34456%2Fjjspnm.56.2_218&rft.externalDocID=130007899052 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1348-964X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1348-964X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1348-964X&client=summon |